Martín Lázaro Quintela
Martín Lázaro Quintela publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Diagnosis and Treatment.
- World rank
- #5,619,374 of 7,710,434 ranked researchers
- Rank in Spain
- #133,206 of 204,306
- Works
- 52
- Citations
- 194
- Citations per work
- 3.7
What does Martín Lázaro Quintela research?
Martín Lázaro Quintela's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4076.5%
- Medicine4076.5%
- Everything else918.1%
- Life Sciences35.4%
- 1Pulmonary and Respiratory Medicine36% of their works
- 2Oncology26% of their works
- 3Radiology, Nuclear Medicine and Imaging7% of their works
- 4Molecular Biology5% of their works
- 5Surgery4% of their works
- 6Hepatology4% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Cancer Treatment and Pharmacology
- Radiopharmaceutical Chemistry and Applications
- Hepatocellular Carcinoma Treatment and Prognosis
- Renal cell carcinoma treatment
Which keywords describe Martín Lázaro Quintela's research?
The keywords of their largest research topics: Clinical Trials, Genomic Profiling, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Genetic Mutations, Immunotherapy and CT Screening.
- Renal Cell Carcinoma
- Liver Cancer
- Taxanes
- PET Imaging
- Prostate Cancer
- Treatment
- Lung Cancer
- CT Screening
- Genetic Mutations
- ALK Inhibitors
- Genomic Profiling
- Clinical Trials
- Targeted Therapy
- EGFR Mutations
- Immunotherapy
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Androgen Receptor
- Chemotherapy-Induced Peripheral Neuropathy
- Radiopharmaceuticals
- Hepatocellular Carcinoma
- Metastatic
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Clinical Trials302 topics
- Genomic Profiling302 topics
- Targeted Therapy282 topics
- ALK Inhibitors211 topic
- EGFR Mutations211 topic
- Genetic Mutations152 topics
- Immunotherapy152 topics
- CT Screening131 topic
- Immune Checkpoint Blockade131 topic
- Lung Cancer131 topic
- PD-1 and PD-L1131 topic
- Treatment122 topics
- Androgen Receptor91 topic
- Prostate Cancer91 topic
- Chemotherapy-Induced Peripheral Neuropathy71 topic
- PET Imaging71 topic
- Radiopharmaceuticals71 topic
- Taxanes71 topic
- Hepatocellular Carcinoma61 topic
- Liver Cancer61 topic
- Metastatic61 topic
- Renal Cell Carcinoma61 topic
Where does Martín Lázaro Quintela work?
Martín Lázaro Quintela's main affiliation in the publication record is University Hospital Complex Of Vigo, Spain.
How many publications and citations does Martín Lázaro Quintela have?
OpenAlex counts 52 works and 194 citations for Martín Lázaro Quintela, an h-index of 7, ranking #5,619,374 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Martín Lázaro Quintela. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.